Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM184B | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | ZNF528 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | RBAK-RBAKDN | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | HIRA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | NPFFR2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | ANKRD54 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | GALK2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | ALDOA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |